Relay Therapeutics Q3 EPS $(0.37) Beats $(0.40) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.40) by 7.5 percent. This is a 13.95 percent increase over losses of $(0.43) per share from
Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.40) by 7.5 percent. This is a 13.95 percent increase over losses of $(0.43) per share from the same period last year.